Evidence suggests that adoption of oncology biosimilars in Medicare value-based payment models has produced substantial cost ...
First Tracks Biotherapeutics, spun off from AnaptysBio, launches with $180M cash and a diverse, early-stage pipeline. Read ...
Clinical Trials Arena on MSN
J&J’s soft tissue surgical robot succeeds in pivotal gastric bypass study
The medtech giant hopes to bolster its position in the growing surgical robotics market, which is currently dominated by Intuitive Surgical.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results